The aim of this project is to engineer brain-targeted nanoparticles to efficiently deliver novel therapeutic agents for the treatment of neurodegenerative diseases (e.g., Parkinson’s and Alzheimer’s Disease), which currently affect 15% globally and are increasing due to aging populations.
Read more